Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm

dc.creatorBarone E.
dc.creatorDi Domenico F.
dc.creatorCassano T.
dc.creatorArena A.
dc.creatorTramutola A.
dc.creatorLavecchia M.A.
dc.creatorCoccia R.
dc.creatorButterfield D.A.
dc.creatorPerluigi M.
dc.date.accessioned2020-09-02T22:12:58Z
dc.date.accessioned2022-11-08T20:23:53Z
dc.date.available2020-09-02T22:12:58Z
dc.date.available2022-11-08T20:23:53Z
dc.date.created2020-09-02T22:12:58Z
dc.date.issued2016
dc.identifier91, , 127-142
dc.identifier08915849
dc.identifierhttps://hdl.handle.net/20.500.12728/3681
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5145034
dc.languageen
dc.publisherElsevier Inc.
dc.subject3xTg-AD mice
dc.subjectAlzheimer disease
dc.subjectBiliverdin reductase-A
dc.subjectInsulin resistance
dc.subjectOxidative stress
dc.subject3 nitrotyrosine
dc.subject4 hydroxynonenal
dc.subjectamyloid beta protein
dc.subjectbiliverdin reductase a
dc.subjectcarbonyl derivative
dc.subjectinsulin
dc.subjectinsulin receptor
dc.subjectinsulin receptor substrate 1
dc.subjectmammalian target of rapamycin
dc.subjectmessenger RNA
dc.subjectoxidoreductase
dc.subjectprotein carbonyl
dc.subjecttau protein
dc.subjecttumor necrosis factor alpha
dc.subjectunclassified drug
dc.subjectbiliverdin reductase
dc.subjectoxidoreductase
dc.subjecttarget of rapamycin kinase
dc.subjecttumor necrosis factor
dc.subjectaging
dc.subjectAlzheimer disease
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectArticle
dc.subjectcomparative study
dc.subjectcontrolled study
dc.subjectenzyme activity
dc.subjecthippocampus
dc.subjectimmunohistochemistry
dc.subjectimmunoreactivity
dc.subjectin vitro study
dc.subjectinsulin resistance
dc.subjectinsulin treatment
dc.subjectlongitudinal study
dc.subjectmale
dc.subjectmouse
dc.subjectneuroblastoma cell
dc.subjectnitration
dc.subjectnitrosative stress
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectpriority journal
dc.subjectprotein blood level
dc.subjectprotein phosphorylation
dc.subject129 mouse
dc.subjectAlzheimer disease
dc.subjectanimal
dc.subjectC57BL mouse
dc.subjectenzymology
dc.subjectgenetics
dc.subjecthuman
dc.subjectmetabolism
dc.subjectprotein processing
dc.subjecttransgenic mouse
dc.subjecttumor cell line
dc.subjectAging
dc.subjectAlzheimer Disease
dc.subjectAnimals
dc.subjectCell Line, Tumor
dc.subjectHippocampus
dc.subjectHumans
dc.subjectInsulin Resistance
dc.subjectMale
dc.subjectMice, 129 Strain
dc.subjectMice, Inbred C57BL
dc.subjectMice, Transgenic
dc.subjectOxidative Stress
dc.subjectOxidoreductases Acting on CH-CH Group Donors
dc.subjectProtein Processing, Post-Translational
dc.subjectTOR Serine-Threonine Kinases
dc.subjectTumor Necrosis Factor-alpha
dc.titleImpairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm
dc.typeArticle


Este ítem pertenece a la siguiente institución